Alain Schreiber, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 129,024 shares at $62.45 ($8.1M) on 2016-09-06, disclosed to the SEC on 2016-09-08.
Open-market sale of $8.1M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.45 | 12,958 | $809K | 10.0% |
| 2 | $62.45 | 12,958 | $809K | 10.0% |
| 3 | $62.83 | 166 | $10K | 0.1% |
| 4 | $62.83 | 49 | $3K | 0.0% |
| 5 | $63.25 | 12,224 | $773K | 9.6% |
| 6 | $62.26 | 75 |
| $5K |
| 0.1% |
| 7 | $62.26 | 22 | $1K | 0.0% |
| 8 | $62.26 | 11,345 | $706K | 8.8% |
| 9 | $62.26 | 11,345 | $706K | 8.8% |
| 10 | $62.33 | 66 | $4K | 0.1% |
| 11 | $62.33 | 224 | $14K | 0.2% |
| 12 | $62.33 | 33,796 | $2.1M | 26.2% |
| 13 | $62.33 | 33,796 | $2.1M | 26.2% |
| Total | $62.43 avg | 129,024 | $8.1M | 100% |
| Filing → |
| IMDZ | SELL | 2015-03-12 | $3.2M | — | Filing → |
| EGRX | BUY | 2014-02-20 | $5.0M | — | Filing → |
| AVNR | SELL | 2009-08-13 | $3.2M | — | Filing → |